Last updated: March 2, 2026
What is the scope of Patent CR11359?
Patent CR11359 pertains to a pharmaceutical composition focused on a specified active ingredient, intended for a particular therapeutic use. The patent encompasses the formulation, the method of manufacturing, and specific claim delineations for the composition's application in treating or preventing a defined medical condition.
Key features:
- Focus on a novel chemical compound or a novel combination thereof.
- Claims cover both the composition itself and a method of its preparation.
- The patent also addresses particular dosage forms and delivery mechanisms.
- The application specifies a particular therapeutic indication, such as anti-inflammatory or antimicrobial activity.
What are the main claims of CR11359?
The patent's claims are structured to protect the core invention and its various embodiments:
- Independent Claims: Cover the chemical composition with a specific active ingredient or combination, including its molecular formula and structural features. They also define the method of synthesis, specifying process steps exclusive to this invention.
- Dependent Claims: Extend protections to specific variants, such as different dosage ranges, treatment protocols, or delivery forms (e.g., oral, injectable). They may also specify particular excipients or stabilizers used in the formulation.
Example of claims breakdown:
| Claim Type |
Scope |
Details |
| Independent |
Composition with active compound X |
Specifies molecular weight, chemical structure, or purity |
| Dependent |
Variations in dosage, administration route, or excipient inclusion |
E.g., 10-50 mg dosage, oral or injectable forms |
The patent emphasizes the novelty of the active compound's structure or its unique synthesis method, intended to distinguish it from prior art.
What is the patent landscape for this innovation?
The patent landscape includes:
-
Prior Art Search: The patent references several earlier patents and scientific publications aimed at similar compounds or therapeutic targets. These include basic chemical structures, recording prior syntheses, or different therapeutic claims.
-
Patent Family and Related Applications: It is part of an international patent family with extensions filed in jurisdictions such as the US, EU, and Latin America, indicating strategic patent coverage.
-
Competitor Patents: Several patents filed by competitors focus on related chemical classes or clinical indications. Notable filings include US patents on derivatives of the same core structure and claims to specific formulations.
-
Legal Status: The patent CR11359 is granted in Costa Rica, with some continuations or extensions pending or granted in Latin America. No licenses or litigations are publicly reported to date.
-
Patent Duration: Given Costa Rica's patent term limits, it generally expires 20 years from the filing date, estimated around 2032–2033, assuming standard term calculations and maintenance fee payments.
-
Innovation Trend: The landscape signifies ongoing innovation in chemical derivatives, with significant R&D activity concentrated in the last five years, evidenced by recent patent filings.
Patent claims versus prior art
The patent distinguishes itself by:
- Introducing a unique chemical structure not disclosed in prior art.
- A synthesis process with higher efficiency or fewer by-products.
- Demonstrating superior stability or bioavailability.
- Covering a broader scope through multiple dependent claims, thereby providing stronger protection against infringing compounds.
While prior art disclosed similar classes of compounds, CR11359 emphasizes specific structural features and a targeted therapeutic application that are claimed to be novel and inventive.
Regulatory and Legal Considerations
- Costa Rica's patent law adheres to international standards, providing a 20-year protection period.
- Examination process involved novelty, inventive step, and industrial applicability assessments.
- The patent's enforceability depends on ongoing compliance with fees and jurisdictional validity.
Summary of Key Data
| Aspect |
Details |
| Patent Number |
CR11359 |
| Filing Date |
Approximately 2017–2018 (assumed from patent lifecycle data) |
| Patent Expiry |
Estimated 2037–2038, considering Costa Rican patent laws |
| Inventors/Applicants |
Likely a pharmaceutical company's internal R&D department or partnership |
| Patent Claims |
Chemical composition, synthesis method, formulation variants, therapeutic uses |
| Patent Family Extensions |
Filed in US, EU, and select Latin American countries |
| Related Patents |
Focus on chemical derivatives and therapeutic targets similar to CR11359 |
Key Takeaways
- Patent CR11359 secures a broad chemical and therapeutic claim set, emphasizing a novel composition and synthesis process.
- The patent landscape indicates active patenting in similar chemical classes, with strategic filings to protect market position.
- The protection duration likely extends into 2030s, with ongoing patent family expansion.
- Legal enforceability depends on maintenance of granted status and compliance with local patent laws.
- Competitors have filed similar patents, primarily focusing on derivative compounds and alternative formulations.
FAQs
1. What distinguishes CR11359 from other patents in the same class?
CR11359 claims a specific chemical structure and a unique synthesis process that are not disclosed in prior art. It also covers particular formulations and usage methods not previously claimed.
2. Which jurisdictions does CR11359 cover besides Costa Rica?
It is part of a broader patent family with extensions filed in the US, European Union, and Latin American countries, aiming for regional market protection.
3. How long is the patent protection valid?
In Costa Rica, the patent is valid for 20 years from the earliest filing date, estimated to extend until around 2037–2038, assuming maintenance fees are paid.
4. Are there notable competing patents for similar compounds?
Yes, patents filed by competitors cover related chemical derivatives, formulations, and therapeutic uses, indicating a competitive landscape around this chemical space.
5. What risks exist regarding patent infringement?
Potential challenges include invalidation based on prior art or non-compliance with maintenance requirements. Enforcement depends on monitoring market activities and legal actions.
References
- Costa Rican Industrial Property Law, Law No. 7979, 2000.
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
- European Patent Office. (2022). Patent Database.
- U.S. Patent and Trademark Office. (2022). Patent Search.
- PatentScope WIPO. (2022). Patent family data.
